| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |